VASO Corp
VASOOTCHealthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $89.1M | $86.8M | $81.0M | $80.0M | $75.6M | $69.8M |
| Operating income | −$2.9M | $285,000 | $4.2M | $7.0M | $2.8M | $772,000 |
| Net income | $1.6M | $951,000 | $4.8M | $11.9M | $6.1M | $358,000 |
| Total assets | $88.3M | $82.9M | $75.8M | $72.7M | $52.4M | $50.4M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $29.4M | $27.7M | $26.8M | $22.9M | $11.3M | $5.1M |
| EPS (diluted) | $0.01 | $0.01 | $0.03 | $0.06 | $0.04 | $0.00 |
| Shares out. | 175.7M | 175.3M | 175.1M | 175.1M | 174.9M | 174.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3.2%
- Net margin
- 1.8%
- Return on equity
- 5.3%
- Return on assets
- 1.8%
- Return on capital (ROCE)
- −5.6%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.17
- Revenue growth (YoY)
- 2.7%
- Net income growth (YoY)
- 65.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −8.7%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 14, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2021
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2019
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2012
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2012
- NT 10-Qmissed a reporting deadline ↗Oct 15, 2002
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ma JunActivist (13D)Apr 16, 2026
- Markowitz JoshuaActivist (13D)Apr 10, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 60,519 | 1.0 | +100.0% |
| Apr 15, 2026 | 4,966 | 1.0 | -90.9% |
| Mar 31, 2026 | 54,734 | 1.0 | +1926.4% |
| Mar 13, 2026 | 2,701 | 1.0 | +270000.0% |
| Feb 27, 2026 | 1 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 8, 2026
- Amended charter or bylawsFeb 12, 2026
- Shareholder voteDec 19, 2025
- Other material eventNov 20, 2025
- Director / officer changeJan 3, 2025
- Terminated a material agreement · Other material eventSep 19, 2024
- Shareholder vote · Other material eventSep 10, 2024
- Other material eventAug 28, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QQUARTERLY REPORTMay 15, 2026
- 8-KCURRENT REPORTMay 8, 2026
- SCHEDULE 13DApr 16, 2026
- SCHEDULE 13DApr 10, 2026
- 10-KANNUAL REPORTMar 31, 2026
- 8-KCURRENT REPORTFeb 12, 2026
- 8-KCURRENT REPORTDec 19, 2025
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSNov 26, 2025
- 8-KCURRENT REPORTNov 20, 2025
- 10-QQUARTERLY REPORTNov 14, 2025
- DEF 14APROXY STATEMENTNov 5, 2025
- 10-QQUARTERLY REPORTAug 14, 2025
- 10-QQUARTERLY REPORTMay 15, 2025
- 10-KANNUAL REPORTMar 31, 2025
- 8-KCURRENT REPORTJan 3, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.